SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ESH Acquisition Corp. is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded on November 17, 2021 and is headquartered in New York, NY.

ESH Acquisition Corp - Ordinary Shares - Class A

ESHA is currently trending due to its exceptionally low public float and high insider ownership, drawing intense comparisons to recent high-flying SPACs like AFJK. The community is highly bullish, anticipating significant price appreciation as a potential business combination announcement approaches for this US-based SPAC. Traders are actively discussing its potential for explosive moves driven by supply scarcity, aligning with patterns observed in other low-float market plays.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is trending due to the recent FDA approval of NEREUS (tradipitant), marking the first new motion sickness drug in over four decades. The community is actively discussing its potential to alleviate GLP-1 induced nausea, viewing this as a significant market opportunity and a catalyst for potential buyouts. While some initially expressed mixed reactions to price action, many believe the stock's long-term value and additional pipeline catalysts are not yet fully reflected.

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BigBear.ai is trending amid a contentious and repeatedly postponed shareholder vote on increasing authorized shares, sparking intense debate over its future funding and growth strategy. Bulls anticipate significant, often classified, government contracts and strategic benefits from the Ask Sage acquisition, viewing current price movements as short-term manipulation. Conversely, skeptics express frustration with management, citing a lack of tangible contract announcements and fearing potential dilution, leading to a polarized community discussion.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull ($BULL) is trending due to widespread discussion around year-end tax loss selling and persistent selling from early investors, which is currently driving significant downward pressure. Community sentiment remains sharply divided, with some seeing current levels as a compelling buying opportunity given the company's profitability and growth, while others emphasize ongoing dilution concerns and a challenging market backdrop.

Aimei Health Technology Co., Ltd. is a blank check company, which engages in entering a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses. The company was founded on April 27, 2023 and is headquartered in New York, NY.

Aimei Health Technology Co Ltd

Aimei Health Technology Co Ltd (AFJK) is trending as traders speculate on a classic "China IPO squeeze" due to its notably low float and thin share structure. The community is actively discussing its highly volatile, casino-like movements, frequent trading halts, and comparing its potential for rapid price swings to similar recent Chinese tickers.

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.

Corcept Therapeutics Inc

Corcept Therapeutics is trending amidst intense speculation regarding an unconfirmed FDA decision on its relacorilant drug for Cushing's Syndrome, with community chatter divided between rumored rejection causing panic selling and calls to buy the dip. The immediate uncertainty around this key pipeline asset, alongside its existing revenue-generating drug Korlym and other promising indications like ovarian cancer, fuels a volatile debate among investors.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood is trending amidst mixed analyst sentiment driven by concerns over crypto trading volumes, despite a strong 2025 performance. The community is buzzing with frustration over app glitches and modest rewards from recent holiday giveaways, fueling discussions about the platform's reliability and marketing approach. Investors are keenly watching how its crypto correlation and new ventures like prediction markets will shape its near-term outlook.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. TeraWulf will generate domestically produced bitcoin powered by nuclear, hydro and solar energy. The company was founded by Paul Prager and Nazar Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulf (WULF) is trending amidst diverse community sentiment following its successful closing of a $1.3 billion project-level financing for a major AI/HPC data center, an event bulls view as a strong validation of its strategic pivot. While supporters see this and recent zoning approvals as foundational for future growth and a buying opportunity, others express frustration over persistent price weakness, attributing it to broader market volatility and perceived manipulation.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

Axsome Therapeutics is trending as investors eagerly await an FDA decision on its AXS-05 supplemental NDA for Alzheimer's disease agitation, viewed as a significant catalyst for an underserved market. This anticipation is fueled by consistently strong and growing prescription numbers for Auvelity in major depressive disorder, reflecting robust commercial execution. The company's expanding CNS pipeline and positive analyst sentiment continue to reinforce its perceived long-term value within the biopharmaceutical sector.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. The company has three commercial products: Gvoke, Keveyis, and Recorlev. Gvoke is ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. Its product also includes Ogluo which is used for the treatment of severe hypoglycemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Xeris Biopharma is currently experiencing a surge in attention fueled by high expectations for its upcoming earnings report, with the community anticipating strong revenue growth driven by its high-margin drug Recorlev. Investors are also keenly focused on the company's pathway to sustained profitability and the long-term potential of its pipeline, particularly the promising XP-8121, which analysts believe could achieve blockbuster status. This positive outlook is supported by recent analyst target upgrades and a perceived de-risked profile, positioning Xeris for significant growth within the biopharma sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Nippon Steel completes acquisition of U.S. Steel in historic deal

Investing.com - Nippon Steel Corporation (TSE: 5401) has finalized its acquisition of United States Steel (NYSE:X), the companies announced Wednesday. The deal, valued at approximately $14.9 billion, creates what the companies describe as a "world-leading steelmaker."

Jefferies downgrades Nippon Steel on U.S. Steel deal risks

Investing.com -- Jefferies has lowered its rating on Nippon Steel Corp (TYO:5401) stock to Underperform, citing multiple financial and operational risks tied to its planned acquisition of United States Steel (NYSE:X).

Trump Approves Nippon's $14.9B Deal For US Steel Deal — But Retail Sentiment Stays BearishU.S President Donald Trump approved Nippon Steel’s bid for U.S. Steel (X) worth $14.9 billion on Friday.Although U.S. Steel shares ended Friday down 2.8%, the news triggered a 5.1% rebound in aftermarket trading, pushing the stock up to $54.85.The companies have also signed a National Security Agreement (NSA) with the U.S. Government, committing to around $11 billion in new investments by 2028. The NSA includes an initial investment in a greenfield project expected to be completed after 2028.The agreement also outlines commitments related to governance, domestic production, and trade, including the issuance of a Golden Share to the U.S. Government, which grants it special voting rights in certain situations. However, neither company disclosed further details regarding the Golden Share.Last month, Republican Senator David McCormick of Pennsylvania indicated that the U.S. would likely hold veto powers over key decisions at the 124-year-old firm.White House trade adviser Peter Navarro echoed the sentiment, “U.S. Steel owns the company. Nippon Steel is going to have some involvement but no control.”The deal will mark the conclusion of a turbulent 18-month period for Nippon Steel in its bid to acquire the American company, a process marked by multiple challenges, including union resistance and two national security reviews.Alongside President Trump’s Executive Order, the companies have also completed the U.S. Department of Justice review process.Retail sentiment on Stocktwits remained ‘bearish’ with users apprehensive about the deal's conclusion.<stembedurl>https://stocktwits.com/Slingshot849/message/617928576</stembedurl><stembedurl>https://stocktwits.com/Slingshot849/message/617918982</stembedurl>One user said that the stock is overpriced and could fall to $30 levels.<stembedurl>https://stocktwits.com/Slingshot849/message/617914605</stembedurl>Year-to-date, the stock has gained around 53% as of Friday’s close.For updates and corrections, email newsroom[at]stocktwits[dot]com.

United States President Donald Trump departs at the White House to U.S. Steel's Irvin Works in West Mifflin, Pennsylvania in Washington D.C May 30, 2025. (Photo by Celal Gunes/Anadolu via Getty Images)

Trump Approves Nippon's $14.9B Deal For US Steel Deal — But Retail Sentiment Stays Bearish

The companies have also signed a National Security Agreement with the U.S. Government, committing to around $11 billion in new investments by 2028

Equity

U.S. Steel (X) continued to garner retail attention on Tuesday after reports and the comments from a lawmaker indicated that the U.S. would likely hold veto powers over key decisions at the 124-year-old firm.The stock rose 2% during the regular trading session, after touching a 14-year high on Friday when Trump indicated his approval for the company’s merger with Japan’s Nippon Steel."It'll be a U.S. CEO, a U.S. majority board, and then there will be a golden share, which will essentially require U.S. government approval of a number of the board members, and that will allow the United States to ensure production levels aren’t cut and things like that," said Republican Senator David McCormick of Pennsylvania in a CNBC interview.The first-time senator’s comments followed a report by Nikkei, which mentioned that Nippon and the U.S. were exploring the issuance of a so-called golden share, which allows the holders of such shares to outvote others in some specific cases.However, McCormick did not elaborate on the administration’s final decision on the original $14.9 billion acquisition deal.Bloomberg <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2025-05-27/us-set-to-receive-golden-share-as-part-of-us-steel-nippon-deal">reported</a>, citing people familiar with the matter, that the agreement tabled in front of the Committee on Foreign Investment in the U.S. (CFIUS) and the Trump administration included the original $55 per share offer alongside additional investments.It was also not clear whether the powers granted to the U.S. would include an equity stake or just mitigation powers, the report added.The deal, announced in December 2023, has faced numerous roadblocks, with both Joe Biden and Trump voicing their opposition to the agreement during an intense campaign in the crucial swing state of Pennsylvania.Biden even blocked the deal during the last days of his administration after the first CFIUS review on national security grounds. Trump ordered a fresh review following requests by both the companies and even the Japanese Government.On Friday, Trump announced a partnership that would bring $14 billion to the U.S. economy and keep the company U.S.-owned without divulging details.Retail sentiment on Stocktwits was ‘extremely bullish’ (80/100) territory, while retail chatter was ‘extremely high.’<figure class="image"><img style="aspect-ratio:882/106;" src="https://news.stocktwits-cdn.com/X_May_28_JPG_bcbe604d26.webp" alt="X’s Sentiment Meter and Message Volume as of 03:10 a.m. ET on May 28, 2025 | Source: Stocktwits" width="882" height="106"><figcaption>X’s Sentiment Meter and Message Volume as of 03:10 a.m. ET on May 28, 2025 | Source: Stocktwits</figcaption></figure>“Let's wrap this deal before anyone changes their mind. I expect a quick close,” one user said.<stembedurl>https://stocktwits.com/drbrain00/message/615989900</stembedurl><a href="https://stocktwits.com/symbol/X">U.S. Steel stock</a> has gained 55% year to date (YTD).Also See: <a href="https://stocktwits.com/news-articles/markets/equity/southwest-airlines-could-net-430-m-from-new-baggage-fees-says-analyst-but-retail-traders-stay-cautious/ch0oeUkRbrt">Southwest Airlines Could Net $430M From New Baggage Fees, Says Analyst — But Retail Traders Stay Cautious</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

A general view of the exterior of the U.S. Steel Tower, headquarters of USX Steel, on March 20, 2024, in Pittsburgh, Pennsylvania. (Photo by Jeff Swensen/Getty Images)

America Likely To Get Veto Powers After US Steel’s Merger With Nippon, Retail Cheers

Nippon and the U.S. were exploring the issuance of a so-called golden share, which allows the holders of such shares to outvote others in some specific cases.

Asia stocks mixed amid Trump tariff uncertainty; Japan extends gains

Investing.com-- Most Asian markets were a mixed bag on Monday after U.S. President Donald Trump threatened and then backtracked on increased European trade tariffs over the weekend, while Japanese shares extended a run of recent gains.

Nippon Steel shares surge after Trump supports US Steel deal

Investing.com-- Shares of Japan’s Nippon Steel Corp (TYO:5401) jumped on Monday after U.S. President Donald Trump expressed support for the company’s $14.9 billion bid to acquire U.S. Steel (NYSE:X).

US panel divided over Nippon Steel’s proposed takeover of US Steel – Reuters

Investing.com-- A U.S. national security panel delivered a divided recommendation to President Donald Trump on Nippon Steel Corp’s (TYO:5401) proposed takeover of U.S. Steel Corp (NYSE:X), though most members believe any risks can be mitigated, Reuters reported on Thursday, citing a White House official.

Nippon Steel shares soar as Trump orders new review of US Steel takeover

Investing.com-- Nippon Steel shares rose sharply on Tuesday after U.S. President Donald Trump ordered a new review of the company’s takeover of U.S. Steel, which was blocked by the Biden administration. 

Shares of United States Steel Corp. (X) surged by more than 7.5% in Thursday’s after-market hours&nbsp;as Japan’s Nippon Steel Corp. (NPSCY)&nbsp;reportedly considers boosting its investment to&nbsp;rebuild its American rival’s facilities.&nbsp;Nippon Steel and U.S. Steel are in talks with the Trump administration as they seek the government’s approval for the $14.1 billion takeover bid, according <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.semafor.com/article/03/27/2025/us-steel-and-nippon-are-in-talks-to-revive-merger-that-trump-had-threaten-to-block">to</a> a Semafor report, citing people familiar with the matter.Nippon has tried to sweeten its takeover bid by significantly increasing its investment pledge to $7 billion from $2.7 billion. This investment will be made in rebuilding U.S. Steel’s aging manufacturing facilities.This comes at a time when Nippon’s acquisition bid for U.S. Steel is stuck in limbo after the Biden administration blocked it on national security grounds.On his part, President Donald Trump has publicly voiced his opposition to Nippon’s acquisition offer. In a&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://truthsocial.com/@realDonaldTrump/posts/113586503722263487">post</a> on his social media platform Truth Social, Trump said, “I am totally against the once great and powerful U.S. Steel being bought by a foreign company, in this case Nippon Steel of Japan.”However, another <a href="https://stocktwits.com/news-articles/markets/equity/us-steel-stock-surges-on-reports-that-trump-is-considering-allowing-acquisition-by-nippon/chPzHvXRt7">report</a> in February stated that Trump might be amiable to the deal, but it was not definite at the time.While the Nippon Steel deal is in limbo, Cleveland-Cliffs Inc. (CLF) and Nucor Corp. (NUE) were&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/us-steel-stock-steady-ahead-of-q4-earnings/chbAYwvRqI">reportedly</a> interested in a joint bid to acquire U.S. Steel.Amid this, U.S. Steel’s first-quarter <a href="https://stocktwits.com/news-articles/markets/equity/us-steel-stock-declines-aftermarket-on-weak-guidance/ch788SVRbPs">guidance</a> came in below Wall Street expectations. The company expects a loss per share between $0.49 and $0.53, while the consensus estimate was for a loss of $0.33 per share.Retail sentiment on Stocktwits around U.S. Steel remained in the ‘extremely bullish’ (91/100) territory, showing exuberance among investors.<figure class="image"><img style="aspect-ratio:645/148;" src="https://news.stocktwits-cdn.com/X_retail_sentiment_jpg_fefc3e4bf2.webp" alt="X retail sentiment.jpg" width="645" height="148"><figcaption>X sentiment and message volume March 27, 2025, as of 9:30 pm ET | Source: Stocktwits</figcaption></figure>One user quipped it’s “time to ride.”<stembedurl>https://stocktwits.com/ucla44life/message/609477986</stembedurl>Another recommends investors use the “buy on dips” strategy to accumulate U.S. Steel shares.<stembedurl>https://stocktwits.com/ucla44life/message/609454751</stembedurl>Data from Koyfin shows the average price target for U.S. Steel is $41.44, which is lower than the stock’s closing price on Thursday.Of the 10 brokerage calls, six either have a ‘Buy’ or a ‘Strong Buy’ recommendation, while four have a ‘Hold’ rating.<a href="https://stocktwits.com/symbol/XTIA">US Steel’s stock</a> has gained over 26% year-to-date.For updates and corrections, email newsroom[at]stocktwits[dot]com.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/xtia-stock-nosedives-on-proposed-public-offering/chJduWJRbEg">XTIA Stock Nosedives On Proposed Public Offering, Retail Turns Bearish</a>

Nippon Steel And US Steel Take Legal Actions Against U.S. Government

US Steel Stock Surges After-Hours As Nippon Reportedly Mulls Boosting Investment Offer: Retail Stays Ultra-Bullish

Nippon will use the funds to rebuild US Steel’s aging manufacturing facilities.

Nippon, US Steel merger talks persist, Trump approval sought- Semafor

Investing.com-- Nippon Steel Corp (TYO:5401) and U.S. Steel (NYSE:X) have remained in active talks to preserve their $14 billion merger agreement and are also negotiating with the Donald Trump administration, Semafor reported on Thursday. 

NIPPON STEEL CORP. engages in the manufacture and trade of steel products. It operates through the following segments: Steel Manufacturing, Engineering, Chemicals & Materials and System Solutions. The Steel Manufacturing segment produces and distributes steel sheets, plates, bars and wire rods, pipes and tubes, and machinery parts. The Engineering segment develops steel plants, heat management facilities, and industrial machinery and equipment. The Chemicals & Materials segment produces and trades chemical products, carbon materials, epoxy resins, semiconductors, stainless-steel foils, silicon carbide wafers, carbon fibers, and metal substrates for catalytic converters. The System Solutions segment includes information technology infrastructure services. The company was founded on April 1, 1950 and is headquartered in Tokyo, Japan.

NPSCY
Nippon Steel Corporation - ADR

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest NPSCY News

NPSCYNippon Steel Corporation - ADR